Warning Letter News
Most Popular Warning Letter Story
Hyaluron contamination response earns FDA warning
Inadequate follow-up after the discovery of particle contamination and poor aseptic technique on the production line highlight GMP violations in Warning Letter NWE-10-18W. The letter's recipient,... Read more...
Latest Headlines
- August 25, 2010
- July 28, 2010
- July 28, 2010
- April 14, 2010
- March 23, 2010
- February 24, 2010
- January 26, 2010
- January 5, 2010
- December 1, 2009
- November 17, 2009
- November 12, 2009
- November 4, 2009
- November 4, 2009
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
